![Ronald Aldridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ronald Aldridge worked as a Senior Director of Investor Relations at PAREXEL International Corp.
from 2016 to 2017.
He also worked as the Head of Investor Relations at The Nassau Cos.
of New York, Inc. and as an Investor Relations Contact at Constellation Pharmaceuticals, Inc.
Former positions of Ronald Aldridge
| Companies | Position | End |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Investor Relations Contact | 2017-09-30 |
| CONSTELLATION PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| THE PHOENIX COMPANIES, INC. | Public Communications Contact | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
16
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
The Nassau Cos. of New York, Inc.
 The Nassau Cos. of New York, Inc. Multi-Line InsuranceFinance Operates as a holding company with interest in providing annuities, life and health insurance services | Finance |
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs targeting regulators of epigenetic function | Health Technology |
- Stock Market
- Insiders
- Ronald Aldridge
